galactose has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Cunha-Oliveira, T; Deus, CM; Oliveira, PJ; Pereira, FB; Pereira, SP; Raimundo, N | 1 |
| Cao, Y; Liu, H; Liu, X; Song, M; Xiao, H; Xiao, J; Zhang, X | 1 |
| Chaturbhuj, SG; Das, M; Gourishetti, K; Kanojia, U; Kishore, A; Krishnadas, N; Nayak, PG; Sankhe, R; Surubhotla, R | 1 |
| Ito, K; Liu, C; Sekine, S; Song, B | 1 |
| Araki, T; Nakazono, O; Sanuki, Y; Tsurui, K | 1 |
| Couch, L; Guo, L; Qing, T; Ren, Z; Shi, L; Tolleson, WH; Xuan, J | 1 |
| Beyrath, J; Iannetti, EF; Koopman, WJH; Smeitink, JAM; Willems, PHGM | 1 |
| Hanaoka, K; Kato, J; Kawamura, T; Miyazaki, Y; Morimoto, K; Nakashima, A; Sugai, K; Takahashi, D; Takahashi, H; Tanaka, M; Ueda, H; Yamaguchi, Y; Yokoo, T | 1 |
| Bennekou, SH; Carta, G; Cediel, A; Delp, J; Forsby, A; Funke, M; Gardner, I; Jennings, P; Leist, M; Rudolf, F; Toma, C; van de Water, B; van der Stel, W | 1 |
| Chang, L; Guo, Z; Li, H; Liu, J; Liu, X; Long, J; Xiao, K; Yang, Y; Zhang, C; Zhao-Wilson, X | 1 |
| Bolszak, M; Hakkola, J; Hinttala, R; Koivunen, P; Komulainen, T; Lodge, T; Morten, KJ; Pietilä, M; Poulton, J; Uusimaa, J | 1 |
| Dou, DQ; Gao, MB; Li, CB; Li, HC; Li, XT | 1 |
| Bai, Y; Fan, W; Haas, R; Huang, T; Huang, VH; Sharma, LK; Simon, M; Wallace, DC; Zhang, C | 1 |
| Alexeyev, MF; Bonilla, G; Pastukh, V; Shokolenko, I; Venediktova, N; Wilson, GL | 1 |
14 other study(ies) available for galactose and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects.
Topics: Aged; Energy Metabolism; Fibroblasts; Galactose; Glucose; Humans; Male; Metabolic Diseases; Middle Aged; Mitochondria; Mitochondrial Diseases; Oxidative Phosphorylation; Oxygen Consumption; Parkinson Disease; Pyruvic Acid; Skin; Substantia Nigra | 2020 |
Astaxanthin attenuates d-galactose-induced brain aging in rats by ameliorating oxidative stress, mitochondrial dysfunction, and regulating metabolic markers.
Topics: Aging; Animals; Behavior, Animal; Biomarkers; Brain; Chromatography, Liquid; Galactose; Membrane Potential, Mitochondrial; Mitochondrial Diseases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Xanthophylls | 2020 |
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction.
Topics: Aging; Aluminum Chloride; Animals; Cognitive Dysfunction; Dementia; Disease Models, Animal; Galactose; Hippocampus; Lipid Peroxidation; Male; Maze Learning; Mitochondrial Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Polycyclic Sesquiterpenes; Rats; Rats, Sprague-Dawley | 2021 |
Use of Primary Rat Hepatocytes for Prediction of Drug-Induced Mitochondrial Dysfunction.
Topics: Animals; Cell Respiration; Chemical and Drug Induced Liver Injury; Culture Media; Energy Metabolism; Forecasting; Galactose; Hepatocytes; Hyperoxia; L-Lactate Dehydrogenase; Mitochondrial Diseases; Oxygen Consumption; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Toxicity Tests | 2017 |
A rapid mitochondrial toxicity assay utilizing rapidly changing cell energy metabolism.
Topics: Adenosine Triphosphate; Chemical and Drug Induced Liver Injury; Drug Discovery; Energy Metabolism; Galactose; Glycolysis; Hep G2 Cells; High-Throughput Screening Assays; Humans; Mitochondria, Liver; Mitochondrial Diseases; Oxidation-Reduction; Phosphorylation | 2017 |
Mitochondrial dysfunction induced by leflunomide and its active metabolite.
Topics: Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Bongkrekic Acid; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Galactose; Glucose; Hep G2 Cells; Humans; Isoxazoles; L-Lactate Dehydrogenase; Leflunomide; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Phosphorylation | 2018 |
Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD
Topics: Adenosine Triphosphate; Aspartic Acid; Cell Death; Culture Media; Electron Transport Complex I; Fibroblasts; Galactose; Gene Expression; Glycolysis; Humans; Ketoglutaric Acids; Leigh Disease; Malates; Mitochondria; Mitochondrial Diseases; Mutation; NAD; NADH Dehydrogenase; Oxaloacetic Acid; Primary Cell Culture; Pyruvic Acid; Skin | 2018 |
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.
Topics: Adult; Deafness; Diabetes Mellitus, Type 2; Female; Galactose; Humans; Immunoglobulin A; Mesangial Cells; Mitochondrial Diseases; Pedigree | 2018 |
Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants.
Topics: Carbohydrate Metabolism; Culture Media; Electron Transport; Electron Transport Complex I; Galactose; Glucose; Humans; Mitochondria; Mitochondrial Diseases; Neural Stem Cells; Neurites; Neurotoxicity Syndromes; Toxicity Tests; Uncoupling Agents | 2019 |
D-galactose induces a mitochondrial complex I deficiency in mouse skeletal muscle: potential benefits of nutrient combination in ameliorating muscle impairment.
Topics: Animals; Disease Models, Animal; Electron Transport Complex I; Female; Galactose; Humans; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Muscle, Skeletal | 2014 |
Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
Topics: Adenosine Triphosphate; Anticonvulsants; Cell Death; Cell Proliferation; Cell Respiration; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Galactose; Glucose; Hep G2 Cells; Hepatocytes; Humans; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Diseases; Oxidative Phosphorylation; Oxidative Stress; Pyruvic Acid; Reactive Oxygen Species; Superoxide Dismutase; Time Factors; Valproic Acid | 2015 |
Protective effects on mitochondria and anti-aging activity of polysaccharides from cultivated fruiting bodies of Cordyceps militaris.
Topics: Aging; Animals; Antioxidants; Cordyceps; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Fruiting Bodies, Fungal; Galactose; Hydroxyl Radical; Injections, Subcutaneous; Liver; Male; Mice; Mice, Inbred Strains; Mitochondria; Mitochondrial Diseases; Phytotherapy; Polysaccharides; Reactive Oxygen Species; Superoxides; Thiobarbituric Acid Reactive Substances | 2010 |
Heteroplasmic mutations of the mitochondrial genome cause paradoxical effects on mitochondrial functions.
Topics: Adenosine Triphosphatases; Adult; Apoptosis; Carrier Proteins; Cell Proliferation; Cells, Cultured; Electron Transport Complex I; Galactose; Genome, Mitochondrial; Humans; Hybrid Cells; Male; Membrane Proteins; Mitochondria; Mitochondrial Diseases; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation; Oxygen Consumption; Point Mutation; Reactive Oxygen Species | 2012 |
Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
Topics: Adenosine Triphosphate; Adenoviridae; Blood Platelets; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Coculture Techniques; Deoxyribonucleases, Type II Site-Specific; DNA, Mitochondrial; Galactose; Gene Deletion; Genetic Engineering; Genetic Markers; Genetic Therapy; Genetic Vectors; Genome, Mitochondrial; Humans; Lactic Acid; Mitochondrial Diseases; Mutation; Oxidative Phosphorylation; Transduction, Genetic | 2008 |